NCT04623515

Brief Summary

Investigators propose a retrospective cohort study to examine the impact of radiation therapy on the global pelvic floor function of women who have completed the immediate surveillance period for colorectal cancer

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 10, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

May 5, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2022

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

11 months

First QC Date

November 5, 2020

Last Update Submit

November 1, 2023

Conditions

Keywords

Survivors of colorectal cancerLower bowel tract symptomsUrinary incontinenceIrritative voiding symptomsVoiding dysfunctionBowel incontinenceDefecatory dysfunctionLower urinary tract symptoms

Outcome Measures

Primary Outcomes (1)

  • Urinary Dysfunction - International Consultation on Incontinence Questionnaire - Female Lower Urinary Tract Symptoms (ICIQ-FLUTS)

    The ICIQ-FLUTS is a 12-item validated, self-administered questionnaire that is derived from the Bristol Female Lower Urinary Tract Symptoms (BF-LUTS) questionnaire and designed for use in women and to assess urinary symptoms and effects on quality of life. There are 3 subscales within this instrument to assess incontinence, voiding and filling. Investigators will specifically use the incontinence subscale as the primary outcome. The instrument is based on 5 questions, with possible answers on a 5-point scale (ranging from "never" to "all of the time"). Scoring is 0-48 with higher scores equaling to a greater bother with urinary dysfunction in participants.

    Up to 4 months

Secondary Outcomes (5)

  • PROMIS® Brief Profile Sexual Function and Satisfaction (Female)

    Up to 4 months

  • Bowel Dysfunction - Modified Manchester Health Questionnaire

    Up to 4 months

  • PROMIS® Brief Profile Sexual Function and Satisfaction- Male or Female Partners

    Up to 4 months

  • Dyadic Adjustment Scale-Short Form (DAS-7) Questionnaire - Couple Relationship

    Up to 4 months

  • Short Form-12 Questionnaire - General Health and Well Being

    Up to 4 months

Study Arms (2)

Surgery Only Group

Participants will complete a questionnaires regarding demographics and medical history on a secured REDCap link.

Other: REDCap Questionnaires

Surgery and Radiation Therapy Group

Participants will complete a questionnaires regarding demographics and medical history on a secured REDCap link.

Other: REDCap Questionnaires

Interventions

Once consent is obtained, the participants will be routed to a REDCap secure link. Participants will complete a questionnaires regarding demographics and medical history. Participants will also complete validated questionnaires regarding their lower urinary and bowel tract function and sexual health- International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms (ICIQ-FLUTS), Modified Manchester Health Questionnaire (MMHQ), PROMIS® v2.0 Brief Profile Sexual Function and Satisfaction (Female) and SF-12 ® .

Surgery Only GroupSurgery and Radiation Therapy Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female survivors of colorectal cancer and their partners.

You may qualify if:

  • Living, female patients.
  • Age 18 or older with a diagnosis of colorectal cancer (current or past, regardless of Stage)-confirmed by pathology report - made between the years of 2015 and 2018.
  • History of treatment for colorectal cancer in the Wake Forest Baptist Health System.
  • Sexual partners of the above participants (subjects can participate even if they are not sexually active or if no sexual partner is available).
  • English speaking.

You may not qualify if:

  • No internet access.
  • Non-English speakers (validated instruments are only available in English).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Health

Winston-Salem, North Carolina, 27103, United States

Location

MeSH Terms

Conditions

Colorectal NeoplasmsUrinary IncontinenceFecal IncontinenceLower Urinary Tract Symptoms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Candace Parker-Autry, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2020

First Posted

November 10, 2020

Study Start

May 5, 2021

Primary Completion

April 14, 2022

Study Completion

April 14, 2022

Last Updated

November 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations